MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis
about
A Novel Type of Non-coding RNA, nc886, Implicated in Tumor Sensing and SuppressionMicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysisNon-coding RNAs in lung cancerSerum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysisMicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisCirculating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokersTherapeutic use of microRNAs in lung cancerA large scale gene-centric association study of lung function in newly-hired female cotton textile workers with endotoxin exposureNicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cellsA novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyIdentification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3.MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 DeletionmiR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells.Prognostic value of miR-21 in various cancers: an updating meta-analysis.nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancerA novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.MicroRNAs As Biomarkers For Clinical Features Of Lung CancerMicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2.Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyActivation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN geneMicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaUnique microRNA-profiles in EGFR-mutated lung adenocarcinomas.What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysisPlasma microRNA panel for minimally invasive detection of breast cancermicroRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cellsHsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling.Identification of miR-145 targets through an integrated omics analysis.miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.
P2860
Q26801690-F5D5AA50-C9E9-485F-BD12-D06A3B6477AFQ26851333-2BFEC1F7-8D2B-4DCD-AB67-EBD03B190064Q26866521-56262621-22D9-47D5-975D-123134878B8BQ27023210-10485E17-6FEC-43BB-A76A-ECBB921F429EQ28236122-A635BE8D-4656-4F7E-9103-3A9785A46AA7Q28271675-BD68EAF7-F8B1-4262-84CE-98415E67D169Q28391728-64C0C2CC-6417-4E42-9D1C-60C381204D40Q28395179-2677AA5D-E0B2-49E6-806F-F37D4365A5D7Q28395921-7985ECFE-9856-4C3C-8F8E-8ACF935576A2Q28534961-FCD1D4E8-EFF5-4763-A6CA-6870FFC76790Q28543958-11739AFD-87C2-43BB-96E1-B282EED94EE5Q33579721-36E899FA-6DA7-4FCA-BD9B-8D533CF6E8CEQ33648562-8A5467A6-3D63-49A7-8472-F45412E576DEQ33670677-41C79ED6-F238-4AB5-B9D9-A8F15DA29C6DQ33776774-4A10837B-17F9-427F-9968-7DBC66D379DEQ33837378-116EF4D3-1A68-4712-8D38-F02336A3296EQ33899211-C432FF59-8891-49CB-AEE7-6FF2FBFABE05Q33977148-D119BE23-AB44-40A8-9959-0D0471F60CDFQ34008192-46C279CC-6450-4EB0-B4EE-0DEBC4B1B533Q34036145-2F1D35B5-FEF1-4888-8499-5DF9B8D03E6AQ34110307-2586C4BD-BC8C-4A30-A333-D29814658E1DQ34158964-3E5A527B-61E1-4A89-82B4-D625968768F6Q34169033-C47F4421-F050-41B0-9744-2AFF2F96155FQ34181700-B389FE89-FA7D-4214-BBB5-9D2A92C204B1Q34248579-DFE0179C-0CC3-4F0A-AE98-01F2CB501C2CQ34252178-418D7C9B-5D38-460B-8BAA-F9D493CAB5DCQ34436424-8A166274-EA1E-4123-9F4E-C8FBC8D19A65Q34443746-38FA8282-95E0-42B0-AE21-4158FA852C8DQ34485641-19A720A5-1205-459A-81A7-F2909882DD67Q34531091-99D94B53-8EC3-46CA-93BF-6F3D0F7C4FA6Q34619416-1CA86F24-4F63-45DD-9222-09141FEB8AF1Q34637868-3307D619-3DD5-411C-9BE7-F8146E83960AQ35032320-394A3B02-F990-4C87-A3FC-D70ECA6311A9Q35042133-A36D7213-D257-46F1-AB44-EC5DEB11D434Q35125641-D1C366EE-0BA1-4316-BDE5-1F538B77BFC0Q35126362-38ABE3CD-801E-41DD-911E-7F73CB3AE6E0Q35155627-34165B02-298D-4840-A117-D586ADBDEF24Q35238507-216D43A1-9EF5-4967-B382-A858A8CE614FQ35496606-B68EAD73-A42C-44E6-9F57-636A0E08BDE5Q35561695-0DB67284-6BAE-4704-8E12-50502204E66D
P2860
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MiR-21 overexpression in human ...... ed with poor patient prognosis
@ast
MiR-21 overexpression in human ...... ed with poor patient prognosis
@en
MiR-21 overexpression in human ...... ed with poor patient prognosis
@nl
type
label
MiR-21 overexpression in human ...... ed with poor patient prognosis
@ast
MiR-21 overexpression in human ...... ed with poor patient prognosis
@en
MiR-21 overexpression in human ...... ed with poor patient prognosis
@nl
prefLabel
MiR-21 overexpression in human ...... ed with poor patient prognosis
@ast
MiR-21 overexpression in human ...... ed with poor patient prognosis
@en
MiR-21 overexpression in human ...... ed with poor patient prognosis
@nl
P2093
P2860
P3181
P1476
MiR-21 overexpression in human ...... ed with poor patient prognosis
@en
P2093
P2860
P2888
P304
P3181
P356
10.1007/S00432-010-0918-4
P407
P577
2011-04-01T00:00:00Z